Good news for your kids who want to get vaccinated as well, Johnson & Johnson says it is testing its single-dose COVID-19 vaccine in teens. The company will start by adding 16 and 17-year-olds to its phase 2a trials, which have been ongoing since September.
The manufacturers of all three COVID-19 vaccines being used in the United States say they continue to conduct tests and are working to increase production capabilities.
Officials in the Biden administration are not confident that Johnson & Johnson will meet its self-imposed deadline to deliver 20 million COVID-19 vaccines by the end of March, despite the company saying they can deliver.
Right now, the three COVID-19 vaccines on the U.S. market are for adults. You must be 18 or older to get Moderna and Johnson & Johnson vaccines, and 16 or older for the vaccine made by Pfizer. Clinical trials are now underway for younger children.
Drugmaker Merck & Co. will help produce rival Johnson & Johnson’s newly approved coronavirus vaccine in an effort to expand supply more quickly.
There’s a new weapon in the fight against COVID-19. After getting the green light from the Food and Drug Administration, Monday morning, Johnson & Johnson began shipping out the first batch of its new one-dose vaccine. Those shots could be in the arms of nearly four million Americans in the next few days.
Johnson & Johnson’s single shot vaccine was approved and is now available for emergency use. That means millions of more single shot doses will be available to Americans 18 and older this week.
ABC NEWS: The U.S. Food and Drug Administration has authorized use of a third COVID-19 vaccine in the U.S., declaring the Johnson & Johnson vaccine safe and effective in adults 18 and older. “The authorization of this vaccine expands the availability of vaccines, the best medical prevention method for COVID-19, to help us in the fight against this pandemic, which…
The United States could have authorization to begin administering a third COVID-19 vaccine in a few days. Food and Drug Administration advisors are meeting Friday to review the Johnson & Johnson vaccine.
Hope is on the horizon, with the United States potentially just one day away now from getting a third vaccine. Johnson & Johnson is on track to possibly be authorized for emergency use by the Food and Drug Administration.
